ArticleWorld journal of urology2025
The effects of antibiotics use during early life and genetic risk on urolithiasis incidence: a large-scale UK biobank cohort study.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
purposeExposure to antibiotics in early life exerts profound impacts on the gut microbiota and is linked to various diseases. This study investigated the association between long-term or recurrent antibiotics use during early life(LRAU), genetic risk and urolithiasis incidence using a large-scale cohort.
methodsParticipants in the UK Biobank who completed digestive health questionnaire were included in this cohort study. Multivariable Cox proportional hazards regression models were used to estimate the risk of incident urolithiasis for LRAU and polygenic risk score (PRS). Additionally, the potential interaction effects were assessed.
resultsOver a median follow-up of 51 years, 3011 of the 121,746 participants developed urolithiasis. Compared to non-LRAU participants, those with LRAU exhibited higher risks of urolithiasis with HRs of 1.20 (95% CI 1.09-1.31). This association is still significant at 5-year intervals from ages 35 to 60. Participants with high and moderate PRS demonstrated increased risks of urolithiasis compared with low group, with HRs of 1.78 (95% CI 1.62-1.94) and 1.36 (1.23-1.49). When stratified by PRS, the significance of LRAU was no longer evident, but still could bring additional risk. Results in the sensitivity analyses were highly consistent with the primary analyses.
conclusionBoth LRAU and a higher PRS are associated with an increased risk of urolithiasis. This association is significant for LRAU at 5-year intervals from ages 35 to 60. A dose-response correlation between PRS and urolithiasis incidence was indicated. LRAU could bring additional urolithiasis risk in participants with higher genetic risk.
Indexed as
Identifiers
41264027What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.